Financial Performance - Net sales for the three months ended September 30, 2025, were $740,000, while the company had no revenue in the comparable periods of 2024 [78]. - The net loss for the three months ended September 30, 2025, was $1,018,768, compared to a net loss of $428,906 in the Successor 2024 Period [78]. - Net cash used in operating activities for the nine months ended September 30, 2025, was $631,875, including a net loss of $2,218,121 [88]. Expenses - SG&A expenses increased to $999,923 for the three months ended September 30, 2025, compared to $156,091 in the Predecessor QTD Period, primarily due to shares issued for consulting and investor relations services [79]. - SG&A expenses for the nine months ended September 30, 2025, totaled $2,200,504, significantly higher than $654,573 in the Predecessor YTD Period [83]. - Interest expense for the nine months ended September 30, 2025, was $19,720, compared to $67 in the Predecessor YTD Period, primarily due to a new term loan [84]. Liquidity and Funding - As of September 30, 2025, the company had $16,123 in cash and cash equivalents and a borrowing capacity of $80,000 under a Term Loan agreement [85]. - The company expects to raise approximately $4.0 million through a public offering to support liquidity and product development over the next twelve months [86]. Product Development - The company is still in the process of developing and commercializing its products, resulting in inconsequential net sales and cost of sales for both the three and nine months ended September 30, 2025 [78][82]. - The company is taking steps to establish formal processes and controls for disclosure and internal controls as it matures as a public company [102].
Caring Brands(CABR) - 2025 Q3 - Quarterly Report